로딩 중…
지수 로딩 중…
지씨지놈
340450· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,850-6.91%
2026-06-19
Price Chart
지씨지놈-48.18%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 114.71B KRW |
| Revenue | 31.53B KRW |
| Net Income | 2.68B KRW |
| Total Assets | 84.63B KRW |
| Net Assets | 78.27B KRW |
| Value | |
| P/E | 42.76x |
| P/B | 1.47x |
| P/S | 3.64x |
| EV/EBITDA | 453.54x |
| FCF Yield | -0.21% |
| Profitability | |
| ROE | 3.43% |
| ROA | 3.17% |
| Op. Margin | 0.56% |
| Financial Health | |
| Debt Ratio | 8.12% |
| Total Debt | 0 KRW |
| FCF | -241.9M KRW |
| Cash | 35.12B KRW |
| Current Ratio | 18.59x |
| Performance | |
| 1Y Return | -48.18% |
| 1M Return | -26.74% |
| From 52W High | -58.93% |
| 1Y MDD | -55.13% |
| Trading | |
| Volume | 155,341 shares |
| Foreign Own. | 4.30% |
| Per Share | |
| EPS | 199 KRW |
| BPS | 3,344 KRW |
Company Info
GC Genome, established in 2013, is a specialized clinical genomics analysis company that listed on KOSDAQ under special provisions for technology growth companies in 2025. It offers customized molecular diagnostic solutions covering the entire life cycle in four business areas, including obstetrics examinations, and supplies genomics services to domestic tertiary general hospitals and clinics. The company is expanding its domestic and international business, including entering the United States and Thailand, strengthening service quality through technology advancement, and diversifying its product portfolio. GC Genome is headquartered in Yongin-si, Gyeonggi-do.